Business
ViewRay® to Present at the Stifel 2015 Healthcare Conference
ViewRay® to Present at the Stifel 2015 Healthcare Conference.
About this update from Viewray, Inc.
[{"type":"text","content":"\n\n\n\nViewRay® to Present at the Stifel 2015 Healthcare Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nViewRay® to Present at the Stifel 2015 Healthcare Conference\nPR Newswire\nCLEVELAND, Nov. 12, 2015\n\n\n\nCLEVELAND, Nov. 12, 2015 /PRNewswire/ -- ViewRay, Inc. (OTCQB: VRAY) announced today that Chris Raanes, Chief Executive Officer, and David Chandler, Chief Financial Officer, will present at the Stifel 2015 Healthcare Conference on November 18, 2015. This conference includes a formal presentation and will allow institutional investors to meet with Mr. Raanes and Mr. Chandler. \n\nEvent:                Stifel 2015 Healthcare Conference          Date:                  Wednesday, November 18, 2015Time:                 3:45 pm ETParticipants:      Chris Raanes, Chief Executive Officer, and David Chandler, Chief Financial Officer\n\nA live webcast of the presentation will be available by visiting the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 30 days after the date of the presentation.\n\nAbout ViewRay\n\nViewRay, Inc. of Cleveland, Ohio, is a medical device company that develops advanced radiation therapy technology for the treatment of cancer. The MRIdian® system provides continuous soft-tissue imaging during treatment, using MRI-guided radiation therapy, so that clinicians are able to see where the actual radiation dose is being delivered and adapt to changes in the patient's anatomy.\n\nViewRay and MRIdian are registered trademarks of ViewRay, Inc.\n\nViewRay acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the MRI Technology Enabling Expansion of MRI into Rad...